
News from blockislandtimes.com
If you want to know if blockislandtimes.com is credible or reliable, look no further. We rank blockislandtimes.com as Unknown factuality. Find out more about our methodology here.
Information about blockislandtimes.com
Where is blockislandtimes.com located?New Shoreham, United Statesblockislandtimes.com's WebsiteMedia Bias Ratings
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top blockislandtimes.com News

West Virginia · West Virginia(BPT) - For many patients diagnosed with diffuse large B-cell lymphoma (DLBCL), the first step in treatment is a standard regimen of chemotherapy. This approach cures most patients, but research shows that one in three will see their cancer return…See the Story
New clinical trial aims to prevent relapse in patients with DLBCL
77% Center coverage: 79 sources

Ningbo · NingboNINGBO, China, June 22, 2025 /PRNewswire/ -- Risen Energy Co., Ltd. (SZSE: 300118), a globally leading renewable energy company, recently released its 2024 Environmental, Social and Governance (ESG) report, themed "Powering a Better World with Clean Energy." The report highlights…See the Story
Risen Energy Highlights Advancements in Green Manufacturing, Sustainable Development and Corporate Responsibility in 2024 ESG Report
58% Center coverage: 34 sources
Data on Novo Nordisk experimental weight-loss drug show mostly mild side effects
76% Center coverage: 33 sources
Kinterra Capital Submits Proposal to Acquire 100% of New World Resources
57% Center coverage: 35 sources
Harbour BioMed Enters Global Strategic Collaboration with Otsuka to Advance BCMAxCD3 Bispecific T-Cell Engagers
62% Center coverage: 29 sources
EAN Congress: Frequent nightmares triple risk of early death and accelerate ageing, major study finds
66% Center coverage: 29 sources
Breakthrough: Roche's New Hemophilia Drug Achieves Zero Bleeds in Clinical Trial, Challenges Market Leader
66% Center coverage: 24 sources
Lilly's once-weekly insulin efsitora alfa demonstrated A1C reduction and a safety profile consistent with daily insulin in multiple Phase 3 trials
70% Center coverage: 26 sources